News
Fedi Mind Tricks: The Fed’s Strategic Bluff Or Massive Blunder?
It didn't take long for the Fed to release a slew of speakers to start the damage control from the…
VDC: Consumer Staples Dashboard For December
This monthly article series shows a dashboard with aggregate industry metrics in consumer staples. It may also serve as a…
Mercury Systems: Upside In Chip War (NASDAQ:MRCY)
In May 2024, I covered Mercury Systems (NASDAQ:MRCY) marking the stock a buy. However, since then the stock has lost…
Aadi Bioscience: New Data Drives A Beaten Company Down, Not Really Justified
Topline Summary Aadi Bioscience (NASDAQ:AADI) is a microcap developmental biotech placing its bets on a single agent, a nanoliposomal encapsulation…
Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal
Deals and Financings SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to…
PCN: Still Not A Buy As We Look To 2024 (NYSE:PCN)
Main Thesis & Background The purpose of this article is to evaluate the PIMCO Corporate & Income Strategy Fund (NYSE:NYSE:PCN)…
Wolters Kluwer: Zooming In On The Compliance Business (OTCPK:WOLTF)
Elevator Pitch Wolters Kluwer N.V. (OTCPK:WOLTF) stock is awarded a Hold investment rating. I outlined the key positives and negatives…
Cadiz: I Skipped The Speculative 16.5% Yielding Preferreds (NASDAQ:CDZI)
The broad collapse of preferreds from the Fed's fight with inflation has created an intense opportunity to build positions in…